ADORA2A and neoplasm: Multiple groups have shown that genetic deletion or blockade of the A2AR in mice has potent effects in enhancing anti-tumour immunity and reducing tumor growth and metastasis, indicating that targeting the A2AR on immune cells likely has a larger therapeutic effect than targeting this receptor on tumor cells alone [9,110].